Physician profile
Jeffrey Weingarten
NPI 1659358455
$2,004.45
in general payments reported to CMS, 2019-2025
17 companies · $568 in 2025
The $568 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $106 · 2021: $323 · 2022: $294 · 2023: $532 · 2024: $17.44 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.03 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $762.61 | 2019-2023 | Xpress Ent Dilation System |
| Glaxosmithkline, LLC. | $268.74 | 2021-2025 | Nucala |
| Genzyme Corporation | $179.95 | 2019-2025 | |
| Medtronic, INC. | $147.71 | 2023 | Propel |
| Hologic Sales and Service, LLC | $141.55 | 2025 | Coolseal Generator |
| Aerin Medical INC. | $137.20 | 2019-2023 | |
| Alk-Abello, INC | $88.32 | 2020-2024 | Pre-Pen, Alternaria Tenuis, Timothy, Standardized |
| Amgen INC. | $82.54 | 2025 | Tezspire |
| Intersect Ent, INC. | $49.67 | 2020 | |
| Inspire Medical Systems, INC. | $34.32 | 2023-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $21.03 | 2019 | |
| Merck Sharp & Dohme LLC | $20.28 | 2021 | |
| Neurent Medical Limited | $16.46 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Acclarent, INC | $14.50 | 2023 | Acclarent Aera |
| Mimedx Group, INC. | $14.48 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.15 | 2025 | |
| Kaleo, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Weingarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.